FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012622068> ?p ?o ?g. }

• W2012622068 endingPage "1949" @default.
• W2012622068 startingPage "1943" @default.
• W2012622068 abstract "No AccessJournal of UrologyAdult Urology1 Jun 2015Clinical Implications of a Multiparametric Magnetic Resonance Imaging Based Nomogram Applied to Prostate Cancer Active Surveillance M. Minhaj Siddiqui, Hong Truong, Soroush Rais-Bahrami, Lambros Stamatakis, Jennifer Logan, Annerleim Walton-Diaz, Baris Turkbey, Peter L. Choyke, Bradford J. Wood, Richard M. Simon, and Peter A. Pinto M. Minhaj SiddiquiM. Minhaj Siddiqui Current address: Department of Surgery, Division of Urology, University of Maryland, Baltimore, Maryland. More articles by this author , Hong TruongHong Truong More articles by this author , Soroush Rais-BahramiSoroush Rais-Bahrami Current address: Departments of Urology and Radiology, University of Alabama-Birmingham, Birmingham, Alabama. More articles by this author , Lambros StamatakisLambros Stamatakis More articles by this author , Jennifer LoganJennifer Logan More articles by this author , Annerleim Walton-DiazAnnerleim Walton-Diaz More articles by this author , Baris TurkbeyBaris Turkbey More articles by this author , Peter L. ChoykePeter L. Choyke More articles by this author , Bradford J. WoodBradford J. Wood More articles by this author , Richard M. SimonRichard M. Simon More articles by this author , and Peter A. PintoPeter A. Pinto More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2015.01.088AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Multiparametric magnetic resonance imaging may be beneficial in the search for rational ways to decrease prostate cancer intervention in patients on active surveillance. We applied a previously generated nomogram based on multiparametric magnetic resonance imaging to predict active surveillance eligibility based on repeat biopsy outcomes. Materials and Methods: We reviewed the records of 85 patients who met active surveillance criteria at study entry based on initial biopsy and who then underwent 3.0 Tesla multiparametric magnetic resonance imaging with subsequent magnetic resonance imaging/ultrasound fusion guided prostate biopsy between 2007 and 2012. We assessed the accuracy of a previously published nomogram in patients on active surveillance before confirmatory biopsy. For each cutoff we determined the number of biopsies avoided (ie reliance on magnetic resonance imaging alone without rebiopsy) over the full range of nomogram cutoffs. Results: We assessed the performance of the multiparametric magnetic resonance imaging active surveillance nomogram based on a decision to perform biopsy at various nomogram generated probabilities. Based on cutoff probabilities of 19% to 32% on the nomogram the number of patients who could be spared repeat biopsy was 27% to 68% of the active surveillance cohort. The sensitivity of the test in this interval was 97% to 71% and negative predictive value was 91% to 81%. Conclusions: Multiparametric magnetic resonance imaging based nomograms may reasonably decrease the number of repeat biopsies in patients on active surveillance by as much as 68%. Analysis over the full range of nomogram generated probabilities allows patient and caregiver preference based decision making on the risk assumed for the benefit of fewer repeat biopsies. References 1 : Outcomes of localized prostate cancer following conservative management. JAMA2009; 302: 1202. Google Scholar 2 : Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol2007; 177: 2106. Link, Google Scholar 3 : Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades. Eur Urol2012; 61: 1019. Google Scholar 4 : Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol2013; 64: 713. Google Scholar 5 : Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol2013; 190: 1721. Link, Google Scholar 6 : Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates?. J Urol2013; 190: 2020. Link, Google Scholar 7 : Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J Clin Oncol2011; 29: 2185. Google Scholar 8 : Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol2011; 186: 1281. Link, Google Scholar 9 : Documenting the location of prostate biopsies with image fusion. BJU Int2011; 107: 53. Google Scholar 10 : Prostate cancer: value of multiparametric MR imaging at 3 T for detection—histopathologic correlation. Radiology2010; 255: 89. Google Scholar 11 : Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?. Radiology2013; 268: 144. Google Scholar 12 : Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients. BJU Int2012; 110: 1642. Google Scholar 13 : Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA1997; 277: 1445. Google Scholar 14 : Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol2003; 170: 1792. Link, Google Scholar 15 : A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance. Cancer2007; 110: 2441. Google Scholar 16 : Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations. Cancer2007; 110: 2218. Google Scholar 17 : Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy. Cancer2007; 109: 2432. Google Scholar 18 : Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent. Cancer2008; 112: 69. Google Scholar 19 : Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer. BJU Int2012; 109: 1315. Google Scholar 20 : Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort. Eur Urol2011; 60: 920. Google Scholar 21 : A new preoperative nomogram to predict minimal prostate cancer: accuracy and error rates compared to other tools to select patients for active surveillance. J Urol2011; 186: 1811. Link, Google Scholar 22 : International multicentre study examining selection criteria for active surveillance in men undergoing radical prostatectomy. Br J Cancer2012; 107: 1467. Google Scholar 23 : Predictive models for worsening prognosis in potential candidates for active surveillance of presumed low-risk prostate cancer. Int Urol Nephrol2012; 44: 459. Google Scholar 24 : Improving risk stratification in patients with prostate cancer managed by active surveillance: a nomogram predicting the risk of biopsy progression. BJU Int2013; 112: 39. Google Scholar 25 : Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer. Cancer2013; 119: 3992. Google Scholar 26 : Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists. J Urol2013; 189: 2092. Link, Google Scholar © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited byHaywood S, Stephenson A and Klein E (2018) Gene Expression Testing as a Predictor of Adverse Pathology after Radical Prostatectomy: Implications for Choosing Patients for Active SurveillanceUrology Practice, VOL. 4, NO. 2, (140-148), Online publication date: 1-Mar-2017.Recabal P, Assel M, Sjoberg D, Lee D, Laudone V, Touijer K, Eastham J, Vargas H, Coleman J and Ehdaie B (2018) The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active SurveillanceJournal of Urology, VOL. 196, NO. 2, (374-381), Online publication date: 1-Aug-2016.Salami S (2018) Editorial CommentJournal of Urology, VOL. 196, NO. 1, (67-67), Online publication date: 1-Jul-2016.Taneja S (2018) Re: Nine-Year Follow-up for a Study of Diffusion-Weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance CohortJournal of Urology, VOL. 195, NO. 6, (1781-1782), Online publication date: 1-Jun-2016. Volume 193Issue 6June 2015Page: 1943-1949 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.Keywordsbiopsynomogramsmagnetic resonance imagingprostatic neoplasmsriskMetricsAuthor Information M. Minhaj Siddiqui Current address: Department of Surgery, Division of Urology, University of Maryland, Baltimore, Maryland. More articles by this author Hong Truong More articles by this author Soroush Rais-Bahrami Current address: Departments of Urology and Radiology, University of Alabama-Birmingham, Birmingham, Alabama. More articles by this author Lambros Stamatakis More articles by this author Jennifer Logan More articles by this author Annerleim Walton-Diaz More articles by this author Baris Turkbey More articles by this author Peter L. Choyke More articles by this author Bradford J. Wood More articles by this author Richard M. Simon More articles by this author Peter A. Pinto More articles by this author Expand All Advertisement PDF downloadLoading ..." @default.
• W2012622068 created "2016-06-24" @default.
• W2012622068 creator A5022455023 @default.
• W2012622068 creator A5035791837 @default.
• W2012622068 creator A5036618005 @default.
• W2012622068 creator A5038850729 @default.
• W2012622068 creator A5046240395 @default.
• W2012622068 creator A5046416890 @default.
• W2012622068 creator A5052820201 @default.
• W2012622068 creator A5065848215 @default.
• W2012622068 creator A5067425469 @default.
• W2012622068 creator A5068012456 @default.
• W2012622068 creator A5082080836 @default.
• W2012622068 date "2015-06-01" @default.
• W2012622068 modified "2023-09-27" @default.
• W2012622068 title "Clinical Implications of a Multiparametric Magnetic Resonance Imaging Based Nomogram Applied to Prostate Cancer Active Surveillance" @default.
• W2012622068 cites W1512405047 @default.
• W2012622068 cites W1517979051 @default.
• W2012622068 cites W1519924883 @default.
• W2012622068 cites W1605545829 @default.
• W2012622068 cites W1680190948 @default.
• W2012622068 cites W1971237277 @default.
• W2012622068 cites W1973804704 @default.
• W2012622068 cites W1978761040 @default.
• W2012622068 cites W1985625937 @default.
• W2012622068 cites W1990422347 @default.
• W2012622068 cites W2003048954 @default.
• W2012622068 cites W2041812982 @default.
• W2012622068 cites W2042635688 @default.
• W2012622068 cites W2056153636 @default.
• W2012622068 cites W2066668973 @default.
• W2012622068 cites W2086308925 @default.
• W2012622068 cites W2088047624 @default.
• W2012622068 cites W2102558162 @default.
• W2012622068 cites W2110881680 @default.
• W2012622068 cites W2125837480 @default.
• W2012622068 cites W2148844122 @default.
• W2012622068 cites W2151747843 @default.
• W2012622068 cites W2154916249 @default.
• W2012622068 cites W2156549595 @default.
• W2012622068 cites W2162127733 @default.
• W2012622068 cites W2169507870 @default.
• W2012622068 cites W4252605154 @default.
• W2012622068 cites W4294715705 @default.
• W2012622068 doi "https://doi.org/10.1016/j.juro.2015.01.088" @default.
• W2012622068 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6301046" @default.
• W2012622068 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25633923" @default.
• W2012622068 hasPublicationYear "2015" @default.
• W2012622068 type Work @default.
• W2012622068 sameAs 2012622068 @default.
• W2012622068 citedByCount "59" @default.
• W2012622068 countsByYear W20126220682015 @default.
• W2012622068 countsByYear W20126220682016 @default.
• W2012622068 countsByYear W20126220682017 @default.
• W2012622068 countsByYear W20126220682018 @default.
• W2012622068 countsByYear W20126220682019 @default.
• W2012622068 countsByYear W20126220682020 @default.
• W2012622068 countsByYear W20126220682021 @default.
• W2012622068 countsByYear W20126220682022 @default.
• W2012622068 countsByYear W20126220682023 @default.
• W2012622068 crossrefType "journal-article" @default.
• W2012622068 hasAuthorship W2012622068A5022455023 @default.
• W2012622068 hasAuthorship W2012622068A5035791837 @default.
• W2012622068 hasAuthorship W2012622068A5036618005 @default.
• W2012622068 hasAuthorship W2012622068A5038850729 @default.
• W2012622068 hasAuthorship W2012622068A5046240395 @default.
• W2012622068 hasAuthorship W2012622068A5046416890 @default.
• W2012622068 hasAuthorship W2012622068A5052820201 @default.
• W2012622068 hasAuthorship W2012622068A5065848215 @default.
• W2012622068 hasAuthorship W2012622068A5067425469 @default.
• W2012622068 hasAuthorship W2012622068A5068012456 @default.
• W2012622068 hasAuthorship W2012622068A5082080836 @default.
• W2012622068 hasBestOaLocation W20126220682 @default.
• W2012622068 hasConcept C121608353 @default.
• W2012622068 hasConcept C126322002 @default.
• W2012622068 hasConcept C126838900 @default.
• W2012622068 hasConcept C143409427 @default.
• W2012622068 hasConcept C143998085 @default.
• W2012622068 hasConcept C19527891 @default.
• W2012622068 hasConcept C2776235491 @default.
• W2012622068 hasConcept C2780192828 @default.
• W2012622068 hasConcept C2910607126 @default.
• W2012622068 hasConcept C34626388 @default.
• W2012622068 hasConcept C71924100 @default.
• W2012622068 hasConceptScore W2012622068C121608353 @default.
• W2012622068 hasConceptScore W2012622068C126322002 @default.
• W2012622068 hasConceptScore W2012622068C126838900 @default.
• W2012622068 hasConceptScore W2012622068C143409427 @default.
• W2012622068 hasConceptScore W2012622068C143998085 @default.
• W2012622068 hasConceptScore W2012622068C19527891 @default.
• W2012622068 hasConceptScore W2012622068C2776235491 @default.
• W2012622068 hasConceptScore W2012622068C2780192828 @default.
• W2012622068 hasConceptScore W2012622068C2910607126 @default.
• W2012622068 hasConceptScore W2012622068C34626388 @default.
• W2012622068 hasConceptScore W2012622068C71924100 @default.
• W2012622068 hasIssue "6" @default.
• W2012622068 hasLocation W20126220681 @default.
• W2012622068 hasLocation W20126220682 @default.

• next